A Quantitative Genetic Interaction Map of HIV Infection.


Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
16 04 2020
Historique:
received: 23 08 2019
revised: 10 01 2020
accepted: 02 02 2020
pubmed: 23 2 2020
medline: 14 8 2020
entrez: 22 2 2020
Statut: ppublish

Résumé

We have developed a platform for quantitative genetic interaction mapping using viral infectivity as a functional readout and constructed a viral host-dependency epistasis map (vE-MAP) of 356 human genes linked to HIV function, comprising >63,000 pairwise genetic perturbations. The vE-MAP provides an expansive view of the genetic dependencies underlying HIV infection and can be used to identify drug targets and study viral mutations. We found that the RNA deadenylase complex, CNOT, is a central player in the vE-MAP and show that knockout of CNOT1, 10, and 11 suppressed HIV infection in primary T cells by upregulating innate immunity pathways. This phenotype was rescued by deletion of IRF7, a transcription factor regulating interferon-stimulated genes, revealing a previously unrecognized host signaling pathway involved in HIV infection. The vE-MAP represents a generic platform that can be used to study the global effects of how different pathogens hijack and rewire the host during infection.

Identifiants

pubmed: 32084337
pii: S1097-2765(20)30074-5
doi: 10.1016/j.molcel.2020.02.004
pmc: PMC7462049
mid: NIHMS1568844
pii:
doi:

Substances chimiques

CNOT1 protein, human 0
IRF7 protein, human 0
Interferon Regulatory Factor-7 0
Transcription Factors 0
Interferons 9008-11-1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

197-209.e7

Subventions

Organisme : NIGMS NIH HHS
ID : F32 GM108303
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI135990
Pays : United States
Organisme : NCRR NIH HHS
ID : S10 RR028962
Pays : United States
Organisme : NIGMS NIH HHS
ID : P50 GM082250
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027763
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI135972
Pays : United States
Organisme : NIAID NIH HHS
ID : P50 AI150476
Pays : United States
Organisme : NIH HHS
ID : S10 OD018522
Pays : United States
Organisme : NIH HHS
ID : S10 OD026880
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The Krogan Laboratory has received research support from Vir Biotechnology and F. Hoffmann-La Roche. A.M. is a co-founder of Spotlight Therapeutics and Arsenal Therapeutics. A.M. serves on the scientific advisory board of PACT Pharma, is an advisor to Sonoma Biotherapeutics, and was a former advisor to Juno Therapeutics. The Marson laboratory has received sponsored research support from Juno Therapeutics, Epinomics, Sanofi, and a gift from Gilead.

Références

J Virol. 2010 Feb;84(4):2157-63
pubmed: 19939917
Retrovirology. 2013 Feb 15;10:20
pubmed: 23414560
Nat Methods. 2017 Jun;14(6):577-580
pubmed: 28481362
Cell. 2018 Dec 13;175(7):1931-1945.e18
pubmed: 30550790
Bioinformatics. 2012 Aug 15;28(16):2184-5
pubmed: 22743226
Cell. 2005 Nov 4;123(3):507-19
pubmed: 16269340
Crit Rev Biochem Mol Biol. 2012 Jul-Aug;47(4):315-33
pubmed: 22416820
Nat Methods. 2013 May;10(5):427-31
pubmed: 23563794
Cell Host Microbe. 2015 Jul 8;18(1):109-21
pubmed: 26118995
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Nucleic Acids Res. 2014 Dec 16;42(22):e168
pubmed: 25300484
Nat Microbiol. 2019 Dec;4(12):2523-2537
pubmed: 31527793
Bioinformatics. 2004 Jun 12;20(9):1453-4
pubmed: 14871861
Nat Microbiol. 2019 Jun;4(6):985-995
pubmed: 30833725
Nat Rev Mol Cell Biol. 2015 Jan;16(1):30-44
pubmed: 25531226
Nature. 2011 Dec 21;481(7381):365-70
pubmed: 22190034
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
J Int AIDS Soc. 2014 Jan 10;17:18938
pubmed: 24433985
PLoS Pathog. 2012;8(8):e1002896
pubmed: 22956906
Cell Host Microbe. 2010 Mar 18;7(3):221-33
pubmed: 20227665
Biostatistics. 2008 Apr;9(2):321-32
pubmed: 17728317
Bioinformatics. 2014 Sep 1;30(17):2524-6
pubmed: 24794931
Mol Cell Biol. 2002 Oct;22(20):6979-92
pubmed: 12242279
EMBO J. 2013 Mar 6;32(5):688-700
pubmed: 23386060
Genome Biol. 2006;7(7):R63
pubmed: 16859555
Cell Rep. 2016 Oct 25;17(5):1438-1452
pubmed: 27783955
Mol Cell Biol. 1998 Feb;18(2):732-41
pubmed: 9447969
Mol Cell. 2012 Jun 8;46(5):691-704
pubmed: 22681890
Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11290-5
pubmed: 16040803
J Cell Sci. 2009 Jul 1;122(Pt 13):2167-77
pubmed: 19535732
Mol Cell. 1998 Mar;1(4):565-74
pubmed: 9660940
Virology. 1995 Feb 1;206(2):935-44
pubmed: 7531918
Bioinformatics. 2004 Nov 22;20(17):3246-8
pubmed: 15180930
Nat Methods. 2009 Jun;6(6):443-5
pubmed: 19448642
Mol Cell. 2018 Aug 16;71(4):637-648.e5
pubmed: 30118682
Science. 2001 May 18;292(5520):1382-5
pubmed: 11337588
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Cell. 2018 Aug 9;174(4):953-967.e22
pubmed: 30033366
Mol Ther Nucleic Acids. 2014 Dec 02;3:e214
pubmed: 25462530
Nature. 2009 Apr 9;458(7239):732-6
pubmed: 19360080
Nat Med. 2004 Dec;10(12):1359-65
pubmed: 15568033
Nat Methods. 2006 Sep;3(9):696-700
pubmed: 16929314
PLoS One. 2013 May 17;8(5):e63583
pubmed: 23691072
Mol Cell. 2015 Jan 22;57(2):329-340
pubmed: 25616068
Science. 2001 May 18;292(5520):1379-82
pubmed: 11337587
Genome Biol. 2010;11(3):R25
pubmed: 20196867
Bioinformatics. 2007 Nov 1;23(21):2881-7
pubmed: 17881408
EMBO J. 2002 Apr 2;21(7):1764-74
pubmed: 11927560
Hum Gene Ther. 1996 Aug 1;7(12):1405-13
pubmed: 8844199
Bio Protoc. 2014 Dec 20;4(24):
pubmed: 27525295
Genes Dev. 1997 Oct 15;11(20):2633-44
pubmed: 9334326
EMBO Rep. 2013 Dec;14(12):1050-61
pubmed: 24232186
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W113-20
pubmed: 15215362
RNA Biol. 2013 Feb;10(2):228-44
pubmed: 23303381
Science. 2016 Sep 23;353(6306):
pubmed: 27708008
EMBO J. 1988 Apr;7(4):919-29
pubmed: 3402440
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Methods Enzymol. 2010;470:205-31
pubmed: 20946812
Genes Dev. 1999 Nov 15;13(22):2928-33
pubmed: 10579999
Methods. 2006 Dec;40(4):344-52
pubmed: 17101447
Nature. 2015 Sep 24;525(7570):491-5
pubmed: 26344199
Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11778-83
pubmed: 17609381
Mol Biol Cell. 2008 Sep;19(9):3847-58
pubmed: 18596238
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8
pubmed: 9843981
RNA Biol. 2013 Feb;10(2):267-76
pubmed: 23232451
Cell Rep. 2017 Jul 25;20(4):819-831
pubmed: 28746868
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Mol Cell. 2015 Jan 22;57(2):349-60
pubmed: 25544563
Biochim Biophys Acta. 2010 May-Jun;1799(5-6):379-88
pubmed: 20060942
Mol Cell Proteomics. 2014 Sep;13(9):2513-26
pubmed: 24942700
Science. 2003 Nov 7;302(5647):1056-60
pubmed: 14564014
PLoS Pathog. 2011 Aug;7(8):e1002194
pubmed: 21901095
Cell Div. 2016 Jul 13;11:9
pubmed: 27418942
Nat Commun. 2019 Feb 20;10(1):863
pubmed: 30787294
Cancer Discov. 2018 Nov;8(11):1474-1489
pubmed: 30209081
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
J Biomol Screen. 2013 Apr;18(4):453-61
pubmed: 23112084
Nat Biotechnol. 2015 Sep;33(9):985-989
pubmed: 26121415
Plant Cell. 2004 Jul;16(7):1883-97
pubmed: 15208392
Nucleic Acids Res. 2016 Dec 15;44(22):10772-10788
pubmed: 27924037
Front Genet. 2014 May 16;5:137
pubmed: 24904637
Nat Methods. 2013 May;10(5):432-7
pubmed: 23407553
Cell. 2018 Dec 13;175(7):1917-1930.e13
pubmed: 30550789
Cell. 2004 Oct 29;119(3):381-92
pubmed: 15507209
Annu Rev Cell Dev Biol. 2003;19:261-86
pubmed: 14570571
Retrovirology. 2011 Dec 06;8:98
pubmed: 22145813
PLoS Pathog. 2012 Dec;8(12):e1003085
pubmed: 23300442
Mol Cell. 2002 Dec;10(6):1519-26
pubmed: 12504026
Mol Cell. 2010 May 14;38(3):439-51
pubmed: 20471949
Cell Host Microbe. 2011 Nov 17;10(5):426-35
pubmed: 22100159
Nature. 2017 May 25;545(7655):505-509
pubmed: 28514442
Genes Dev. 1997 Oct 15;11(20):2622-32
pubmed: 9334325
Cell. 2010 May 28;141(5):739-45
pubmed: 20510918
Mol Cell. 2013 Jan 24;49(2):222-31
pubmed: 23352243
Mol Cell Proteomics. 2012 Apr;11(4):M111.015313
pubmed: 22174317
Nature. 2007 Apr 12;446(7137):806-10
pubmed: 17314980
Nat Methods. 2017 Jun;14(6):573-576
pubmed: 28319113
Cell. 2013 Aug 15;154(4):775-88
pubmed: 23932120
Science. 2008 Oct 17;322(5900):405-10
pubmed: 18818364
Cell Cycle. 2012 Mar 15;11(6):1142-50
pubmed: 22370482

Auteurs

David E Gordon (DE)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA 94158, USA; Gladstone Institutes, San Francisco, CA 94158, USA.

Ariane Watson (A)

School of Biomolecular and Biomedical Science and Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland; Systems Biology Ireland, University College Dublin, Belfield, Dublin 4, Ireland.

Assen Roguev (A)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA 94158, USA.

Simin Zheng (S)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Gwendolyn M Jang (GM)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA 94158, USA.

Joshua Kane (J)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA 94158, USA.

Jiewei Xu (J)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA 94158, USA.

Jeffrey Z Guo (JZ)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA 94158, USA.

Erica Stevenson (E)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA 94158, USA; Gladstone Institutes, San Francisco, CA 94158, USA.

Danielle L Swaney (DL)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA 94158, USA; Gladstone Institutes, San Francisco, CA 94158, USA.

Kathy Franks-Skiba (K)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA 94158, USA.

Erik Verschueren (E)

Genentech, South San Francisco, CA 94080, USA.

Michael Shales (M)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA 94158, USA.

David C Crosby (DC)

Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94143, USA.

Alan D Frankel (AD)

Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94143, USA.

Alexander Marson (A)

Gladstone Institutes, San Francisco, CA 94158, USA; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA.

Ivan Marazzi (I)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Gerard Cagney (G)

School of Biomolecular and Biomedical Science and Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland; Systems Biology Ireland, University College Dublin, Belfield, Dublin 4, Ireland.

Nevan J Krogan (NJ)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA 94158, USA; Gladstone Institutes, San Francisco, CA 94158, USA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: nevan.krogan@ucsf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH